Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 12 matching records
THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE DEVELOPMENT AND VALIDATION OF BIOTIN AS AN IN VIVO LABELLING AGENT FOR RED BLOOD CELLS TO REPLACE CHROMIUM 51 AS THE STANDARD…Department of Health and Human Services$8.4M obligationsEnds Sep 30, 2027
AWARD TASK ORDER 1 TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT AND FUTURE CCTN ACTIVITIES.Department of Health and Human Services$89.5K obligationsEnds Jul 31, 2026
CONSULTING SERVICES TO DEVELOP MACHINE LEARNING DATA ANALYSISDepartment of Health and Human Services$44.9K obligationsEnds Aug 31, 2023
PARTNERSHIP FOR RESEARCH OF SENSING TECHNOLOGIESDepartment of Health and Human Services$41.0K obligationsEnds Apr 22, 2025
IGF::OT::IGF CONTRACEPTIVE CLINICAL TRIALDepartment of Health and Human Services$407.1K obligationsEnds Sep 30, 2022
IDENTIFYING RISK FACTORS AND DEVELOPING EDUCATION MATERIAL FOR FIRST RESPONDERS FOR OPIOID OVERDOSE SITUATIONSDepartment of Health and Human Services$45.8K obligationsEnds Feb 12, 2025
DEVELOPMENT AND ADOPTABILITY OF EDUCATIONAL MATERIALS FOR FIRST RESPONDERS FOR OPIOID OVERDOSE SITUATIONDepartment of Health and Human Services$9.7K obligationsEnds Feb 12, 2025
UNIVERSITY OF CINCINNATI SILVER BI-ANALYTICS MEMBERSHIPDepartment of Health and Human Services$16.0K obligationsEnds Apr 22, 2025
ACCESS OF EQUIPMENT AND FACILITIES U OF CIN RHODES HALL ROOM 435ADepartment of Health and Human Services$15.0K obligationsEnds Apr 22, 2025
PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIALDepartment of Health and Human Services$190.9K obligationsEnds Dec 31, 2025
IGF::OT::IGF A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL LOW DOSE ULIPRISTAL…Department of Health and Human Services$1.3M obligationsEnds Mar 31, 2022
BIOMARKER DETECTION DEVICES (LAB-ON-A-CHIP DEVICES AND PORTABLE ANALYZER) FOR PERFORMING IMMUNOASSAY IGF::OF::IGFDepartment of Health and Human Services$444.3K obligationsEnds Apr 25, 2022